Granular Delivery TRIZ Cases

A gel-inducible oil composition adheres to a pet's mouth ceiling for reliable drug delivery.

Segmented drying stages prevent melting peak shifts and moisture sensitivity in valsartan solid dosage forms.

Using multi-functional Michael donor solvents eliminates inefficient solvent removal steps during polymerization, improving process productivity.

Segmented drying and milling processes reduce fines content while maintaining precise average particle sizes for taste masking.

Combining Chidamide and Chiauranib overcomes limited efficacy of single agents while minimizing damage to normal cells.

Marine collagen nanoparticles encapsulate abscisic acid to improve bioavailability and reduce adverse effects in cardiac ischemia treatment.

A continuous water-in-oil-in-water emulsion process forms microparticles with controlled morphology and high bioactive agent loading efficiency.

Cold solvent-free extrusion creates a complete lipid coating on spherical pellets, masking taste without toxic excipients or complex multi-step processes.

Photochemical crosslinking stabilizes collagen microspheres, eliminating toxic chemical agents and cytotoxicity risks while maintaining mechanical integrity.

Nighttime extended-release amantadine maintains daytime plasma concentrations while minimizing sleep disturbances.

Milk protein carriers solubilize hydrophobic sterol esters, preventing particle agglomeration and improving bioavailability in food matrices.

Organic cross-linking agents replace toxic metal salts to create biocompatible nanoporous microsponge particles for biomolecule delivery.

Lipid-surfactant coatings mask unpleasant tastes in dispersible oral formulations while maintaining stability for thermolabile active ingredients.

Large phospholipid-coated lipid globules direct energy to subcutaneous tissue, reducing visceral adipose tissue and metabolic disorder risk.

Reverse nanofprecipitation aggregates nanoparticles into microparticles, achieving 80 wt% loading without burst release.

Colloidal silicon dioxide surface treatment reduces stickiness and improves flow characteristics of Bempedoic acid during pharmaceutical granulation.

Carob pulp extract mediates calcium hydroxide nanoparticle synthesis in ethylene glycol.

Merged intaglio and coating steps resolve manufacturing complexity while enabling reliable product differentiation through unique surface features.

Composite lipid-coated silk microspheres overcome phospholipid instability to deliver sustained joint lubrication and therapeutic efficacy.

Microporous hydrogel particles link via radical polymerization to form a stable scaffold.

Seeding pellets and a rolling-bed coating process increase yield of desired fractions while reducing waste in potassium chloride production.

A single-step process where monomers polymerize directly onto API particles to mask bitter tastes and enable controlled drug release without organic solvents.

Hydrophobic polymeric microbeads release oxygen via peroxide decomposition to resolve hypoxia-induced cell death in large-scale cellular implants.

Lipid coating on crystalline ascorbic acid enables sustained release in oral direct granules, resolving swallowing difficulty and foreign body sensation.

Methacrylate copolymer coatings maintain gastric resistance while preventing ethanol-induced drug release, ensuring therapeutic efficacy.

Controlled precipitation replaces mechanical grinding to yield highly crystalline microparticles, avoiding amorphization and broad particle size distribution.

Melt-congeal cores resist water absorption that ruptures sugar cores, enabling controlled drug release from multiparticulates.

Replacing dropping methods with pneumatic spraying eliminates inconsistent drug distribution across pharmaceutical globules.

Gelatinization and freezing of natural starch in an aqueous solution form microspheres with uniform particle size while preserving the molecular structure.

Unsaturated flow promoters in aqueous dispersions react with pendant groups during drying to improve film hardness and durability.

Multi-component particles utilize phase-separated polymeric regions to deliver distinct therapeutic agents.

A traditional Chinese medicine composition combines spleen tonification with tumor dissolution to treat intermediate stage cancer.

Replacing non-degradable monomers with biodegradable peptides eliminates environmental accumulation while maintaining high affinity and selectivity.

Swelling oxidized cellulose in a polar aprotic solvent enables dissolution with lithium halides, preventing harsh condition degradation.

Cyclodextrin inclusion complexes increase withanone and withaferin A levels in ashwagandha water extracts.

Shielded nanofiller grafts to polymeric material, resolving filler-resin compatibility and exfoliation trade-offs.

Melt-formed crystalline polyol microspheres eliminate API incompatibility and rough surface defects to ensure reliable drug delivery.

A sustained-release composition delivers hydrogen sulfide via a paraffin wax and fatty alcohol carrier matrix to promote angiogenesis.

A granular niacin product uses a long-chain fatty acid matrix to achieve controlled intestinal release, preventing gastric flushing and side effects.

Spray-dried mannitol and starch matrix encapsulates long chain polyunsaturated fatty acids in a free-flowing powder.

Continuous strand extrusion and cooling enable precise weight segmentation, resolving the trade-off between production efficiency and manufacturing precision.

A Salvia miltiorrhiza micropellet formulation stabilizes water-soluble and fat-soluble active ingredients within a unified pharmaceutical matrix.

Precise polyvinyl alcohol parameters maintain supersaturation and prevent crystallization, resolving stability issues during pH shifts.

Hydrophilic polymer matrix slows rohitukine release over 24 hours, resolving hygroscopic encapsulation challenges.

Segmented pellets swell to fill partial defects, avoiding necrosis from fat transfer and enabling precise shape restoration.

A polymeric composition comprising a hydrophilic macromonomer, a hydrophobic polymer, and a bridging monomer grafted together to form stable aqueous dispersions.

Ethylene-alpha-olefin interpolymer with controlled Mw/Mn ratio and specific melting point density relationship enhances shear adhesion failure temperature.

Ethylene-alpha-olefin interpolymer adhesive composition with tailored molecular weight and density resolves shear adhesion failure temperature trade-offs.

Sequential polymerization creates multimodal acrylic latexes with distinct molecular weight peaks.

PLGA microparticles sustain PD98059 release to inhibit p-ERK1/2, overcoming short half-life limitations in heart failure treatment.